Bibliographic information
GuidelineWHO recommendations on adolescent health: guidelines approved by the WHO guidelines review committee
Year of Publication2017
Issuing InstitutionWorld Health Organization
Recommendation
New
First-line ART for adolescents should consist of two nucleoside reverse transcriptase inhibitor (NRTI) plus an non-nucleoside reverse transcriptase inhibitor (NNRTI) or an INSTI: TDF + lamivudine (3TC) + dolutegravir (DTG) or tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) or emtricitabine (FTC) + efavirenz (EFV) 4002 may be used as alternative options to initiate ART
Recommended in favor
Conditional
Certainty of evidence
Low